the aid library

LIST OPTIONS

Filter

8486

Classification and minimum standards for Foreign Medical Teams in sudden onset disasters

World Health Organization (WHO) ; Global Health Cluster (2013) C_WHO

The document introduces a simple classification, minimums standards and a registration form for Foreign Medical Teams (FMTs) that may provide surgical and trauma care arriving within the aftermath of a sudden onset disaster. These can serve as tools to improve the coordination of the foreign medical... more

Download (490)

View PDF (1010)

Directives pour l’intégration d’interventions ciblant la violence basée sur le genre dans l’action humanitaire

Inter-Agency Standing Committee IASC, Global Protection Cluster (2015) C1

Réduction des risques, promotion de la résilience et aide au relèvement

Download (273)

View PDF (396)

Optimizing HIV Investments in Armenia

C. Hamelmann; M. Manova; E. Masaki; et al. Armenian National AIDS Center; The Global Fund; UNAIDS; UNDP; International Bank for Reconstruction and Development; et al. (2019) C2

Accessed: 29.09.2019

Download (319)

View PDF (301)

Guide pratique pour la gestion des fausses informations sur les vaccins

PGP, UNICEF, Yale Institute for Global Health (2021) CC

Cette ressource a été élaborée pour faciliter le développement de plans d’action nationaux stratégiques et bien coordonnés afin de contrer rapidement la désinformation sur les vaccins et d’encourager la demande de vaccination éclairée par l’écoute sociale.

Download (325)

View PDF (398)

Report card HIV Prevention for girls and young women

IPPF (International Planned Parenthood Federation); UNFPA; The Global Coalition on Women and AIDS; et al. (2019) C2

Accessed: 24.09.2019

Download (282)

View PDF (459)

Priorities in Operational Research to Improve Tuberculosis Care and Control

Stop TB Partnership; World Health Organization; The Global Fund (2011) C_WHO

External Link

Providing sutstainable mental and neurological health care in Ghana and Kenya

Sheena Posey Norris, Erin Hammers Forstag, and Bruce M. Altevogt Forum on Neuroscience and Nervous System Disorders; Board on Health Sciences Policy; Board on Global Health; Publisher: National Academic Press (2016) C2

Download (359)

View PDF (480)

Vereinnahmung oder echte Transformation?

Marie-Luise Abshagen, Anna Cavazzini, Laura Graen, Wolfgang Obenland Brot für die Welt, Forum Umwelt und Entwicklung, Unfairtobacco, Global Policy Forum, Bischöfliches Hilfswerk Misereor (2018) C2

Download (465)

View PDF (591)

Informing vaccination programs: a guide to the design and conduct of dengue serosurveys

World Health Organization WHO (2020) C_WHO

In this document, recommendations are provided on designing and implementing a cross-sectional serosurvey using school-based sampling to estimate age-specific DENV seroprevalence to inform a country’s national dengue vaccination program. The document includes recommendations for methods for ... more

Download (249)

View PDF (352)

Monitoring HIV impact using population-based surveys

UNAIDS (Joint United Nations Programme on HIVAIDS); World Health Organization (WHO) UNAIDS (Joint United Nations Programme on HIVAIDS); World Health Organization (WHO) (2015) C2

UNAIDS/WHO Working group HIV/AIDS and STI surveillance 2015 / Reference

Download (405)

View PDF (659)

не в ногу 2015 (out of step russian version) Лечение туберкулеза в 24 странах Исследование диагностической и клинической практики

Médecins sans Frontières; Stop TB Partnership (2015) C1

TB policies in 24 Countries A survey of prevention, testing and treatment policies and practices Лечение туберкулеза в 24 странах Исследование диагностической и клинической практики

Download (243)

View PDF (360)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

External Link

A toolkit for national dengue burden estimation

Brady, O. J. et all. WHO (2018) CC

The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden of dengue.

Download (342)

View PDF (289)

Planning and Implementing High-Quality Supplementary Immunization Activities for Injectable Vaccines Using an Example of Measles and Rubella Vaccines

World Health Organization WHO (2016) C_WHO

The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs as the main example throughout, but the informatio... more

Download (163)

View PDF (105)

Neglected Disease Research and Development: The Higher Cost of Lower Funding

G-Finder (2023) CC

Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go... more

External Link

Onchocercose - Lignes directrices pour l’arrêt de l’administration de masse de médicaments et la vérification de l’élimination de l’onchocercose humaine : critères et procédures

Organisation mondiale de la santé OMS (2017) C_WHO

Les présentes lignes directrices ont pour objet de préparer les pays d’endémie à arrêter l’AMM à l’issue du traitement, à passer à la surveillance post-thérapeutique ainsi qu’à confirmer l’interruption de la transmission à l’issue de la phase 2 et à débuter la surveillance p... more

Download (241)

View PDF (378)

Elimination of kala-azar as a public health problem in South-East Asia: template dossier

World Health Organization WHO (2025) C_WHO

This template dossier complements and should be used after fulfilling the criteria and preconditions specified in the Process of validation of elimination of kala-azar as a public health problem in South-East Asia. The national kala-azar programme should be in the consolidation phase of elimination;... more

Download (379)

View PDF (540)

Out of Step in EECA: TB Policies in 8 Countries in Eastern Europe and Central Asia

Médecins sans Frontières MSF Stop TB Partnership (2017) C1

A survey of prevention, testing and treatment policies and practices

Download (420)

View PDF (533)

Situational Analysis Report on Antimicrobial Resistance in Pakistan

The Center for Disease Dynamics, Economics & Policy CDDEP (2016) C2

Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet... more

Download (276)

View PDF (330)

Worldwide rates of diagnosis and effective treatment for cystic fibrosis

Guo, J.; Garratt, A.; Hill, A. Journal of Cystic Fibrosis (2022) CC

Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma... more